HCPCS code J9286 — Inj glofitamab gxbm, 2.5 mg.
Status: Active.
Effective Jan 1, 2024.
Source: CMS HCPCS Level II.
J9286
ActiveInj glofitamab gxbm, 2.5 mg
Injection, glofitamab-gxbm, 2.5 mg
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Jan 1, 2024
Code type:
alphanumeric
OPPS Status:
G
— Pass-through drugs and biologicals
OPPS APC:
0720
MUE — Medically Unlikely Edits
Maximum units of J9286 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| Outpatient Hospital | 12 |
| Practitioner Services | 12 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 50242-0125-01 | Columvi |
| 50242-0127-01 | Columvi |
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2024-Q1Inj glofitamab gxbm, 2.5 mg